Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.
Provan SA, Berg IJ, Hammer HB, Mathiessen A, Kvien TK, Semb AG. Provan SA, et al. Among authors: hammer hb. PLoS One. 2015 Jun 26;10(6):e0130709. doi: 10.1371/journal.pone.0130709. eCollection 2015. PLoS One. 2015. PMID: 26114946 Free PMC article.
Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B, Kristianslund EK, Hammer HB, Fagerli KM, Lie E, Wierød A, Kalstad S, Rødevand E, Krøll F, Haugeberg G, Kvien TK. Michelsen B, et al. Among authors: hammer hb. Ann Rheum Dis. 2017 Apr;76(4):708-711. doi: 10.1136/annrheumdis-2016-210283. Epub 2016 Oct 4. Ann Rheum Dis. 2017. PMID: 27707730
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
Nordal HH, Brokstad KA, Solheim M, Halse AK, Kvien TK, Hammer HB. Nordal HH, et al. Among authors: hammer hb. Arthritis Res Ther. 2017 Jan 12;19(1):3. doi: 10.1186/s13075-016-1201-0. Arthritis Res Ther. 2017. PMID: 28081709 Free PMC article. Clinical Trial.
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.
Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, Wierød A, Kalstad S, Rødevand E, Krøll F, Haugeberg G, Kvien TK. Michelsen B, et al. Among authors: hammer hb. Ann Rheum Dis. 2017 Nov;76(11):1906-1910. doi: 10.1136/annrheumdis-2017-211284. Epub 2017 Jul 21. Ann Rheum Dis. 2017. PMID: 28733473
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Jonsson MK, Sundlisæter NP, Nordal HH, Hammer HB, Aga AB, Olsen IC, Brokstad KA, van der Heijde D, Kvien TK, Fevang BS, Lillegraven S, Haavardsholm EA. Jonsson MK, et al. Among authors: hammer hb. Ann Rheum Dis. 2017 Dec;76(12):2031-2037. doi: 10.1136/annrheumdis-2017-211695. Epub 2017 Aug 16. Ann Rheum Dis. 2017. PMID: 28814431 Clinical Trial.
Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol.
Paulshus Sundlisæter N, Olsen IC, Aga AB, Hammer HB, Uhlig T, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA; ARCTIC study group. Paulshus Sundlisæter N, et al. Among authors: hammer hb. Rheumatology (Oxford). 2018 Nov 1;57(11):2022-2031. doi: 10.1093/rheumatology/key202. Rheumatology (Oxford). 2018. PMID: 30053199
162 results